Your browser is no longer supported. Please, upgrade your browser.
ZTS [NYSE]
Zoetis Inc.
IndexS&P 500 P/E55.21 EPS (ttm)3.71 Insider Own0.10% Shs Outstand475.50M Perf Week0.75%
Market Cap97.91B Forward P/E40.50 EPS next Y5.06 Insider Trans-36.05% Shs Float473.70M Perf Month5.55%
Income1.77B PEG4.35 EPS next Q1.08 Inst Own93.30% Short Float0.72% Perf Quarter17.79%
Sales7.01B P/S13.96 EPS this Y9.90% Inst Trans-0.25% Short Ratio1.90 Perf Half Y31.93%
Book/sh8.60 P/B23.81 EPS next Y12.33% ROA13.10% Target Price191.60 Perf Year31.58%
Cash/sh- P/C- EPS next 5Y12.69% ROE49.10% 52W Range141.41 - 205.67 Perf YTD23.74%
Dividend1.00 P/FCF76.61 EPS past 5Y38.30% ROI14.90% 52W High-0.43% Beta0.64
Dividend %0.49% Quick Ratio2.50 Sales past 5Y7.00% Gross Margin69.60% 52W Low44.82% ATR2.88
Employees11300 Current Ratio3.30 Sales Q/Q22.00% Oper. Margin31.20% RSI (14)67.64 Volatility1.27% 1.42%
OptionableYes Debt/Eq1.76 EPS Q/Q32.50% Profit Margin25.30% Rel Volume1.02 Prev Close204.10
ShortableYes LT Debt/Eq1.61 EarningsAug 05 BMO Payout22.80% Avg Volume1.79M Price204.79
Recom1.90 SMA202.14% SMA508.11% SMA20021.19% Volume1,821,290 Change0.34%
Jul-16-21Downgrade Raymond James Outperform → Mkt Perform
Mar-08-21Upgrade Raymond James Mkt Perform → Outperform $166
Mar-08-21Upgrade BofA Securities Neutral → Buy $180
Sep-21-20Initiated Atlantic Equities Overweight $191
Aug-14-20Upgrade Edward Jones Hold → Buy
Aug-12-20Downgrade Gabelli & Co Buy → Hold
May-27-20Initiated Jefferies Buy $152
Jan-10-20Initiated Raymond James Mkt Perform
Sep-09-19Initiated Goldman Buy $145
Jul-01-19Downgrade BofA/Merrill Buy → Neutral $111 → $120
Jun-11-19Initiated Barclays Overweight $120
May-23-19Initiated Guggenheim Buy $114
May-03-19Downgrade Gabelli & Co Buy → Hold $108
Mar-20-19Initiated SunTrust Hold
Mar-04-19Upgrade Stifel Hold → Buy $97 → $110
Jan-23-19Initiated UBS Neutral $86
Oct-15-18Upgrade JP Morgan Neutral → Overweight
Aug-22-18Downgrade Stifel Buy → Hold $95
Aug-03-18Reiterated Stifel Buy $86 → $95
Apr-19-18Reiterated Citigroup Buy $85 → $98
Aug-04-21 10:39AM  
09:14AM  
08:00AM  
Aug-02-21 09:45AM  
Jul-29-21 03:05PM  
Jul-27-21 11:40AM  
Jul-22-21 12:10PM  
Jul-20-21 08:04AM  
Jul-16-21 06:50PM  
01:54PM  
Jul-15-21 01:43PM  
Jul-08-21 08:10AM  
Jul-07-21 11:40AM  
Jul-02-21 09:35AM  
08:30AM  
Jul-01-21 10:51AM  
Jun-30-21 08:30AM  
Jun-29-21 07:29AM  
Jun-22-21 01:11PM  
Jun-17-21 10:36AM  
Jun-16-21 04:13PM  
10:44AM  
Jun-10-21 08:00AM  
Jun-03-21 08:00AM  
Jun-02-21 08:12AM  
May-31-21 05:16PM  
May-27-21 08:30AM  
May-24-21 08:30AM  
May-20-21 04:30PM  
May-19-21 08:00AM  
May-11-21 07:00AM  
May-10-21 11:40AM  
08:49AM  
May-06-21 07:30PM  
04:39PM  
09:47AM  
08:25AM  
07:00AM  
May-05-21 08:51AM  
May-03-21 05:29PM  
10:00AM  
Apr-30-21 02:13PM  
Apr-29-21 05:02PM  
Apr-22-21 11:40AM  
Apr-20-21 12:10PM  
Apr-19-21 10:05AM  
Apr-16-21 07:14AM  
Apr-13-21 09:39AM  
08:59AM  
Apr-01-21 06:25AM  
Mar-31-21 08:30AM  
07:59AM  
Mar-30-21 04:51PM  
Mar-26-21 09:53AM  
Mar-24-21 08:58AM  
Mar-21-21 10:28AM  
Mar-18-21 11:30AM  
Mar-17-21 11:40AM  
Mar-16-21 08:08AM  
07:32AM  
Mar-15-21 09:22AM  
Mar-13-21 09:34AM  
07:54AM  
Mar-11-21 02:24PM  
Mar-10-21 08:30AM  
Mar-09-21 07:57AM  
Mar-08-21 01:00PM  
10:04AM  
09:51AM  
08:31AM  
Mar-01-21 11:40AM  
Feb-24-21 08:30AM  
Feb-22-21 09:51AM  
08:30AM  
03:00AM  
Feb-17-21 10:08AM  
08:57AM  
Feb-16-21 04:30PM  
04:20PM  
08:41AM  
08:09AM  
07:00AM  
Feb-15-21 10:28AM  
Feb-12-21 08:38AM  
Feb-11-21 12:10PM  
09:35AM  
Feb-10-21 05:14PM  
Feb-09-21 12:30PM  
11:07AM  
Feb-03-21 11:40AM  
Jan-29-21 06:35AM  
Jan-28-21 10:00AM  
Jan-22-21 09:37AM  
Jan-14-21 08:21AM  
Jan-12-21 11:40AM  
Dec-30-20 08:30AM  
Dec-24-20 06:54AM  
Dec-23-20 10:59AM  
Dec-18-20 08:30AM  
Dec-15-20 10:55AM  
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prevent, kill, or slow the growth of bacteria, fungi, or protozoa; and parasiticides that prevent or eliminate external and internal parasites that include fleas, ticks, and worms. It also provides other pharmaceutical products, which comprise pain and sedation, antiemetic, reproductive, and oncology products; Dermatology products for itch associated with allergic conditions and atopic dermatitis; and medicated feed additives that offer medicines to livestock. In addition, the company offers portable blood and urine analysis systems, and point-of-care diagnostic products, including instruments and reagents, rapid immunoassay tests, reference laboratory kits, and blood glucose monitors; and other non-pharmaceutical products, including nutritionals and agribusiness services, as well as products and services in areas, such as biodevices, genetics tests, and precision livestock farming. It markets its products to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lagano RoxanneExecutive Vice PresidentJul 22Option Exercise55.0212,844706,67754,927Jul 26 05:56 PM
Lagano RoxanneExecutive Vice PresidentJul 22Sale199.1822,4504,471,61032,477Jul 26 05:56 PM
Trawicki RomanExecutive Vice PresidentJul 01Option Exercise73.243,285240,5935,702Jul 06 04:22 PM
Trawicki RomanExecutive Vice PresidentJul 01Sale187.004,492840,0041,210Jul 06 04:22 PM
PECK KRISTIN CChief Executive OfficerMay 25Option Exercise30.8912,000370,68045,924May 26 05:16 PM
PECK KRISTIN CChief Executive OfficerMay 25Sale175.4514,5002,544,02631,424May 26 05:16 PM
Knupp Catherine A.Executive Vice PresidentMay 20Sale175.168,2831,450,85053,642May 21 04:39 PM
Lagano RoxanneExecutive Vice PresidentMay 19Option Exercise52.036,000312,15548,083May 21 04:41 PM
Lagano RoxanneExecutive Vice PresidentMay 19Sale169.056,0001,014,30042,083May 21 04:41 PM
Chen Heidi C.Executive Vice PresidentMay 03Option Exercise55.0212,238673,33536,883May 04 04:16 PM
Kelly Robert EdwardExecutive Vice PresidentMay 03Option Exercise28.301,54843,80810,353May 04 04:21 PM
Chen Heidi C.Executive Vice PresidentMay 03Sale175.0112,2382,141,77224,645May 04 04:16 PM
Kelly Robert EdwardExecutive Vice PresidentMay 03Sale174.702,053358,6598,300May 04 04:21 PM
Chen Heidi C.Executive Vice PresidentApr 21Option Exercise55.0211,637640,26836,282Apr 22 04:40 PM
Chen Heidi C.Executive Vice PresidentApr 21Sale170.1411,6371,979,91924,645Apr 22 04:40 PM
Trawicki RomanExecutive Vice PresidentApr 15Option Exercise73.243,285240,5936,908Apr 19 04:03 PM
Trawicki RomanExecutive Vice PresidentApr 15Sale165.004,491741,0152,417Apr 19 04:03 PM
Kelly Robert EdwardExecutive Vice PresidentMar 01Option Exercise28.301,55043,86511,365Mar 03 04:25 PM
Kelly Robert EdwardExecutive Vice PresidentMar 01Sale156.112,055320,8069,310Mar 03 04:25 PM
PECK KRISTIN CChief Executive OfficerFeb 25Option Exercise30.8912,000370,68050,351Mar 01 04:19 PM
PECK KRISTIN CChief Executive OfficerFeb 25Sale158.3716,4272,601,47633,924Mar 01 04:19 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Option Exercise41.836,000250,98048,083Feb 22 04:32 PM
Alaix Juan RamonDirectorFeb 19Option Exercise73.24133,0709,746,047347,377Feb 23 04:59 PM
SCULLY ROBERT WDirectorFeb 19Buy164.687,5901,249,9317,590Feb 23 06:47 PM
Alaix Juan RamonDirectorFeb 19Sale160.55133,07021,363,973214,307Feb 23 04:59 PM
Lagano RoxanneExecutive Vice PresidentFeb 19Sale167.886,0001,007,28042,083Feb 22 04:32 PM
Chen Heidi C.Executive Vice PresidentFeb 18Option Exercise55.0260033,01225,245Feb 22 04:31 PM
Chen Heidi C.Executive Vice PresidentFeb 18Sale170.04600102,02424,645Feb 22 04:31 PM
Trawicki RomanExecutive Vice PresidentFeb 17Option Exercise73.243,285240,5938,114Feb 18 04:54 PM
Trawicki RomanExecutive Vice PresidentFeb 17Sale165.824,491744,6983,623Feb 18 04:54 PM
David GlennChief Financial OfficerFeb 16Option Exercise73.2426,2851,925,11359,186Feb 18 04:56 PM
David GlennChief Financial OfficerFeb 16Sale168.9226,2854,439,96532,901Feb 18 04:56 PM
Kelly Robert EdwardExecutive Vice PresidentFeb 11Option Exercise28.301,55043,86510,758Feb 16 05:16 PM
Kelly Robert EdwardExecutive Vice PresidentFeb 11Sale161.152,054331,0028,704Feb 16 05:16 PM
Chen Heidi C.Executive Vice PresidentDec 01Option Exercise41.831,18049,35917,515Dec 03 05:16 PM
Chen Heidi C.Executive Vice PresidentDec 01Sale161.641,180190,73516,335Dec 03 05:16 PM
PECK KRISTIN CChief Executive OfficerNov 25Option Exercise30.896,500200,78538,374Nov 25 04:42 PM
PECK KRISTIN CChief Executive OfficerNov 25Sale161.5110,5001,695,81027,874Nov 25 04:42 PM
Lagano RoxanneExecutive Vice PresidentNov 19Option Exercise41.836,000250,98041,680Nov 20 04:47 PM
Lagano RoxanneExecutive Vice PresidentNov 19Sale164.066,000984,36035,680Nov 20 04:47 PM
Alaix Juan RamonDirectorNov 13Sale165.4691,74715,180,5614,266Nov 17 04:30 PM
Chen Heidi C.Executive Vice PresidentNov 02Option Exercise41.831,17949,31817,514Nov 03 04:47 PM
Chen Heidi C.Executive Vice PresidentNov 02Sale161.431,179190,32616,335Nov 03 04:47 PM
Chen Heidi C.Executive Vice PresidentOct 01Option Exercise41.831,17949,31817,514Oct 02 06:04 PM
Trawicki RomanExecutive Vice PresidentOct 01Option Exercise55.024,080224,4825,501Oct 02 06:08 PM
Trawicki RomanExecutive Vice PresidentOct 01Sale166.035,501913,3530Oct 02 06:08 PM
Chen Heidi C.Executive Vice PresidentOct 01Sale166.231,179195,98516,335Oct 02 06:04 PM
Rhodes LindaDirectorSep 04Sale159.161,087173,0071,468Sep 08 04:18 PM
Chen Heidi C.Executive Vice PresidentSep 01Option Exercise41.831,17949,31817,514Sep 02 04:48 PM
Chen Heidi C.Executive Vice PresidentSep 01Sale160.711,179189,47716,335Sep 02 04:48 PM
PECK KRISTIN CChief Executive OfficerAug 25Option Exercise30.896,500200,78542,374Aug 26 06:00 PM
PECK KRISTIN CChief Executive OfficerAug 25Sale157.6110,5001,654,88931,874Aug 26 06:00 PM
Lagano RoxanneExecutive Vice PresidentAug 19Option Exercise41.836,000250,98041,680Aug 21 04:27 PM
Lagano RoxanneExecutive Vice PresidentAug 19Sale160.376,000962,22035,680Aug 21 04:27 PM
Reed Willie MDirectorAug 13Sale159.071,885299,8474,635Aug 17 04:23 PM
Knupp Catherine A.Executive Vice PresidentAug 13Sale158.8613,0002,065,16050,368Aug 17 04:26 PM